Identification of antigenic neo-epitopes from in vitro reprogrammed human tissue precursors for regenerative therapy

  • Post author:
  • Post category:

Research Objective This study examine potential immunologic changes caused by cellular reprogramming that could present a barrier to clinical application of regenerative therapies. Impact Identification and evaluation of immunologic changes…

Continue ReadingIdentification of antigenic neo-epitopes from in vitro reprogrammed human tissue precursors for regenerative therapy

Reverse transcriptase inhibitors as a novel therapeutic approach for neurological autoimmune disorders

  • Post author:
  • Post category:

Research Objective We found that approved anti-retroviral drugs could stop inflammation and block neurodegeneration. We propose to validate the re-purpose efficacy of these clinically-approved retroviral drugs. Impact We have identified…

Continue ReadingReverse transcriptase inhibitors as a novel therapeutic approach for neurological autoimmune disorders

Development of a universal allogeneic human interneuron cell therapy candidate for the treatment of drug resistant focal epilepsy.

  • Post author:
  • Post category:

Translational Candidate Development of a universal allogeneic human interneuron cell therapy candidate for the treatment of drug resistant focal epilepsy. Area of Impact Non-destructive treatment option for drug-resistant focal epilepsy…

Continue ReadingDevelopment of a universal allogeneic human interneuron cell therapy candidate for the treatment of drug resistant focal epilepsy.

A high quality, accessible cell therapy for Parkinson’s Disease produced in a scalable bioreactor system for 3D cell expansion and differentiation

  • Post author:
  • Post category:

Translational Candidate Human pluripotent stem cell expanded and differentiated dopaminergic precursor cells to treat Parkinson’s Disease at high quantity and high quality Area of Impact This candidate uses a 3D…

Continue ReadingA high quality, accessible cell therapy for Parkinson’s Disease produced in a scalable bioreactor system for 3D cell expansion and differentiation